Clinical efficacy of 1927-nm fractionated thulium laser in the treatment of facial skin photoaging

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100050801

Enrollment

Unknown

Registered

2021-09-04

Start date

2021-10-01

Completion date

Unknown

Last updated

2022-05-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Photoaging

Interventions

Experimental group:Treatment with 1927 nm thulium

Control group:No

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Facial aging features, such as wrinkles, rough skin, large pores, reduced elasticity, relaxation, dark yellow skin, pigmentation, etc; 2. Aged 18-60 years, no gender limitation; 3. Fitzpatrick skin type II-IV.

Exclusion criteria

Exclusion criteria: 1. Pregnant women and lactation seeking beauty; 2. Scar constitution; 3. Those who have been treated with chemical peeling, laser, intense pulse light and other skin rejuvenation treatments within 6 months; 4. Patients who had received botulinum toxin type A injection or skin and soft tissue filling operation within 6 months; 5. Oral or external use of retinoids within 6 months; 6. With anxiety, depression, schizophrenia and other mental disorders; 7. Patients with infectious skin diseases at the treatment site.

Design outcomes

Primary

Measure	Time frame
VISIA;Physiological index of skin;Global aesthetic improvement scale (GAIS);Visual analogue scale (VAS);Satisfaction;	—

Countries

china

Contacts

Public ContactWen Ju

Guangdong Second Provincial General Hospital

wenju3139@163.com+86 13829764166

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026